Marie-Claire Peakman

Marie-Claire Peakman has an extensive career in the pharmaceutical industry, currently serving as a member of the Board of Directors at TRIMTECH Therapeutics Limited, Normunity, Curve Therapeutics, Mozart Therapeutics, Grey Wolf Therapeutics, and DEM Biopharma. Since December 1999, Marie-Claire has been with Pfizer, where key roles have included Partner at Pfizer Ventures, Executive Director positions in Emerging Science & Innovation, Medicine Design, and heading the Groton and Sandwich Research Centers of Emphasis. Academic credentials include a PhD in Physiology and Pharmacology from the University of Nottingham and a BPharm (Hons) in Pharmacy from the same institution, complemented by education at the Yale School of Medicine.